4.8 Review

Molecular regulation of HDL metabolism and function: implications for novel therapies

Journal

JOURNAL OF CLINICAL INVESTIGATION
Volume 116, Issue 12, Pages 3090-3100

Publisher

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI30163

Keywords

-

Funding

  1. NCRR NIH HHS [M01 RR00040, M01 RR000040] Funding Source: Medline
  2. NHLBI NIH HHS [R37 HL055323, HL22633, HL62250, R01 HL055323, P01 HL022633, HL55323, HL70128, P01 HL062250, P01 HL059407, P50 HL070128, HL59407] Funding Source: Medline
  3. NIDDK NIH HHS [DK06990, R01 DK059533, DK59533] Funding Source: Medline

Ask authors/readers for more resources

HDL metabolism represents a major target for the development of therapies intended to reduce the risk of atherosclerotic cardiovascular disease. HDL metabolism is complex and involves dissociation of HDL apolipoprotein and HDL cholesterol metabolism. Advances in our under standing of the molecular regulation of HDL metabolism, macrophage cholesterol efflux, and HDL function will lead to a variety of novel therapeutics.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available